-
The show-stealing, highly controversial racetrack leader is far from being worth much
"Value Firm" previously tracked several old vaccine companies in the first tier, such as Zhifei Bio, Kangtai Bio and Watson Bio.
2022-12-30 17:43 -
New therapies approved by FDA this year: TCR double antibody, domestic CAR T...
In just three days, 2022 will be history. This year, we witnessed division and union, and felt the warmth of the world.
2022-12-30 17:42 -
The Neglected 'last mile' to Fight cancer
The five-year survival rate of tumors is an important indicator of a country's tumor diagnosis and treatment ability.
2022-12-28 20:06 -
Consino Bio inhalation COVID-19 vaccine arrives in Morocco
The first batch of Kvessa ® Bio-inhalation COVID-19 vaccine has arrived in Morocco, providing an innovative solution for local COVID-19 prevention.
2022-12-28 20:04 -
From 'Class B A Tube' to 'Class B B tube', where is the epidemic concept stock going?
The history of "Class B A tube" has come to an end.
2022-12-28 20:03 -
Deqi Pharmaceutical and Merck reached a global clinical cooperation
ATG-037 is an oral small molecule CD73 inhibitor from Deqi Pharmaceutical. KEYTRUDA® (Pbolizumab) is a PD-1 inhibitor of Merck.
2022-12-28 20:02 -
Huaxia Yingtai STAR-T project was approved as 'orphan drug' by FDA
It marks that Huaxia Yingtai has entered a new stage of clinical development from new drug research and development.
2022-12-27 20:45 -
Supplement of spermidine enhances anti-tumor immune response
Supplement of spermidine can enhance anti-tumor immune response mechanism!
2022-12-27 20:44 -
The vaccine got cold, and many CXOs couldn't sit still
Three years of corona capital is coming to an end.
2022-12-27 20:43 -
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- BASF Launches Second Round of ... Jul 24, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products